Theres still a bit of uncertainty around how GLP-1 medications affect the gut microbiome
It simultaneously activates three hormone receptors that play central roles in metabolism, appetite regulation, and energy balance: Glucagon-like peptide-1 (GLP-1) receptor Glucose-dependent insulinotropic polypeptide (GIP) receptor Glucagon receptor Previous weight loss medications have targeted one or two of these pathways
Catching this early allows for intervention before problems become significant
The company provides these compounds with documentation and quality control data, so researchers can verify product specifications for their studies
To this end, many drugs have been repurposed, including tocilizumab, sarilumab, heparin, chloroquine, ivermectin, sarilumab, chromones (Sestili and Stocchi, 2020)